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Abstract
Background: Sand fly saliva contains potent and complex pharmacologic molecules that are able
to modulate the host's hemostatic, inflammatory, and immune systems. In this study, we evaluated
the effects of salivary gland sonicate (SGS) of Lutzomyia intermedia, the natural vector of Leishmania
braziliensis, on monocytes obtained from the peripheral blood mononuclear cells (PBMC) of healthy
volunteers. We investigated the effects of sand fly saliva on cytokine production and surface
molecule expression of LPS-stimulated human monocytes uninfected or infected with L. braziliensis.
Results: Pre-treatment of non-infected human monocytes with L. intermedia SGS followed by LPS-
stimulation led to a significant decrease in IL-10 production accompanied by a significant increase
in CD86, CD80, and HLA-DR expression. Pre-treatment with SGS followed by LPS stimulation and
L. braziliensis infection led to a significant increase in TNF-α, IL-6, and IL-8 production without
significant alterations in co-stimulatory molecule expression. However, pre-treatment with L.
intermedia SGS did not result in significant changes in the infection rate of human monocytes.
Conclusion: Our data indicate that L. intermedia saliva is able to modulate monocyte response,
and, although this modulation is dissociated from enhanced infection with L. braziliensis, it may be
associated with successful parasitism.
Background
Leishmaniasis is a protozoan parasitic infection transmit-
ted by sand flies. Different species of Leishmania are asso-
ciated with distinct clinical forms of disease. Cutaneous
leishmaniasis (CL) caused by Leishmania major is usually
benign; infection of human hosts leads to the develop-
ment of a localized cutaneous lesion that eventually heals,
leading to the generation of life long-immunity. In con-
trast, CL caused by L. braziliensis is distinguished from
other leishmaniasis by its chronicity, latency, and ten-
dency to metastasize in the human host [1]. In this dis-
ease, a single ulcer with elevated borders and a necrotic
centre is frequently observed, and a chronic inflammatory
response develops despite the paucity of parasites. In
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1–5% of patients, muco-cutaneous leishmaniasis may
occur due to the intrinsic ability of L. braziliensis to persist
within lesion scars after spontaneous or chemotherapy-
mediated healing and its ability to metastasize to the nasal
mucosa [2-4].
Leishmania parasites are transmitted to the vertebrate host
when the sand fly probes for a blood meal. During blood
feeding, sand fly saliva, which contains a great variety of
hemostatic, inflammatory, and immunomodulatory mol-
ecules (rev. in [5]), is injected into the host's skin. Sand fly
saliva is also known to facilitate parasite survival [6-9].
The enhancing effects of sand fly saliva on disease devel-
opment are associated with its ability to inhibit several
functions of antigen presenting cells (APCs) such as anti-
gen presentation and nitric oxide (NO) production [10-
12]. We have recently shown, using an experimental
model of infection, that pre-exposure to Lutzomyia inter-
media saliva is able to enhance infection with Leishmania
braziliensis [13]. Importantly, individuals with active cuta-
neous leishmaniasis also showed higher humoral
immune responses to L. intermedia saliva compared to
control subjects, suggesting an association between posi-
tive anti-saliva immune response and the development of
disease. Therefore, we were interested in determining the
effects of L. intermedia saliva in a more restricted experi-
mental system, employing LPS-stimulated human mono-
cytes alone or infected with Leishmania braziliensis. This
approach has already been undertaken with P. papatasi
[14] and with L. longipalpis [15], with which it was shown
that saliva impairs cytokine production and co-stimula-
tory molecule expression on human monocytes and den-
dritic cells. Monocytes and dendritic cells are present in
the hemorrhagic pool created by sand fly feeding and are,
therefore, exposed to sand fly saliva. Because of this, we
have examined the effects of saliva from L. intermedia, the
main vector of L. braziliensis in Brazil, on human mono-
cytes stimulated with LPS and uninfected or infected with
L. brazilienis. Understanding how salivary products inter-
fere with LPS-induced co-stimulatory molecule expres-
sion, cytokine production, and parasite infection may
help clarify the complex vector-parasite-human host inter-
play.
Results and Discussion
Within their saliva, sand flies have evolved an array of
potent pharmacological components which induce a
favorable microenvironment for adequate blood feeding
and which may also be important for parasite establish-
ment (rev. in [16]). L. intermedia is the sand fly species
responsible for the transmission of Leishmania braziliensis,
the causative agent of cutaneous and mucosal leishmani-
asis; thus, we have investigated the effects of L. intermedia
saliva on the host's immune response in terms of surface
molecule expression and cytokine production. Initially,
we found that human monocytes stimulated with L. inter-
media SGS alone did not secrete detectable levels of IL-
12p40 or of TNF-α (data not shown). For that reason, we
opted to set up an experimental system in which human
monocytes were pre-treated with L. intermedia SGS and
were then stimulated with LPS. In cultures that were pre-
treated with SGS, we observed a significant decrease in IL-
10 production without significant changes in terms of IL-
6, TNF-α or IL-12p40 production (Fig. 1). Modulation of
cytokine profiles following exposure to sand fly SGS has
already been described; P. papatasi saliva was shown to
decrease the production of type 1 cytokines and to
enhance the production of IL-6 by monocytes [14]. Sand
fly saliva from three different species was able to suppress
the mitogen-induced proliferative response of murine
spleen cells [17]. Last, Costa et al. [15] showed, using the
same experimental system employed herein, that L. longi-
palpis SGS inhibits TNF-α and IL-10 production while aug-
menting IL-6, IL-8, and IL-12p40 production. In that
work, it was proposed that components in that sand-fly
saliva may promote the development of a cell-mediated
immune response through the up-regulation of IL-12 and
inhibition of IL-10 production. To that end, development
of a delayed-type hypersensitivity (DTH) response was
associated with protection against leishmaniasis induced
by immunization with SP15, a protein present in P. pap-
atasi saliva [18].
Co-stimulatory molecules play an essential role in the
activation and maintenance of T-cell responses. We thus
analyzed whether pre-exposure to L. intermedia saliva had
any effect on CD80, CD86, and HLA-DR expression.
Monocytes were pre-treated with SGS and stimulated with
LPS, and surface molecule expression was analyzed by
flow cytometry. Surprisingly, pre-treatment with SGS was
able to significantly increase the mean fluorescence inten-
sity (MFI) of CD80, CD86, and HLA-DR on human
monocytes (Fig. 2). Such up-regulation of co-stimulatory
molecule expression was not observed with L. longipalpis
SGS [15], indicating once again that salivary components
of these two sand fly species induce different immu-
nomodulatory effects. We can speculate that the increase
in co-stimulatory molecule expression observed with L.
intermedia saliva may be related to the decreased levels of
IL-10 (Fig. 1) since it was shown that interleukin-10 dif-
ferentially regulates B7-1 (CD80) and B7-2 (CD86)
expression on human peripheral blood dendritic cells
[19]. Class II MHC molecules are required for the activa-
tion of CD4 T cells and protection against L. major [20].
CD80, CD86, and CTLA-4 also influence the immune
response to Leishmania [21,22]. The increased expression
of co-stimulatory molecules also enhances antigen pres-
entation that, ultimately, may lead to increased T cell acti-
vation and IFN-γ production. Indeed, cutaneous
leishmaniasis is associated with an intense inflammatoryBMC Immunology 2008, 9:12 http://www.biomedcentral.com/1471-2172/9/12
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reaction [23,24]. Given these results, we then investigated
whether the immune modulation exerted by L. intermedia
saliva would affect parasite load upon monocyte infection
with  L. braziliensis. To address this hypothesis, human
monocytes were pre-treated with L. intermedia saliva, stim-
ulated with LPS, and then infected with L. braziliensis.
Notably, we observed a significant increase in TNF-α, IL-
6, and IL-8 production upon parasite infection in cultures
pre-treated with SGS, whereas IL-10 levels did not change
(Fig. 3). We did not detect significant differences in CD80,
HLA-DR (Fig. 4) or in CD86 expression (data not shown).
However, up-regulation of the production of TNF-α, IL-6,
and IL-8 following pre-treatment with L. intermedia SGS
and L. braziliensis infection did not change the parasite
load as measured by the number of infected monocytes
(Fig. 5A) or by the number of amastigotes per infected
monocyte (Fig. 5B).
Norsworthy et al. [9] also failed to detect significant
changes in the infection rate of L. amazonensis in murine
macrophages that were pre-treated with L. longipalpis
saliva, despite the significantly higher IL-10 mRNA levels
observed. However, addition of Maxadilan, the potent
vasodilatory peptide present in L. longipalpis saliva, alone
was able to up-regulate IL-10, IL-6 and TGF-β and to
increase the L. major parasite load [25]. We are currently
investigating L. intermedia and L. longipalpis saliva in
terms of differences or similarities in immunomodulatory
compounds and preliminary results indicate that Maxadi-
lan is not abundant in L. intermedia saliva (de Oliveira et
al., manuscript in preparation). SDS-PAGE profiles of sal-
ivary proteins from both sand fly species showed bands
migrating at similar molecular weights, although L. inter-
media immune sera does react with any protein present in
L. longipalpis SGS with the exception of the ~45 kDa pro-
Effect of L. intermedia SGS on LPS-stimulated human monocytes Figure 1
Effect of L. intermedia SGS on LPS-stimulated human monocytes. Monocytes were pre-treated with SGS overnight 
and stimulated with LPS for 24 h (TNF-α and IL-6) or 48 h (IL-10 and IL-12p40). The presence of IL-10 (A), IL-6 (B), TNF-α (C) 
and IL-12p40 (D) was analyzed by ELISA. The data for individual donors are presented. (*p < 0.05). (n = 10)BMC Immunology 2008, 9:12 http://www.biomedcentral.com/1471-2172/9/12
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tein [13], indicating differences in the immunogenicity of
salivary molecules.
It is well known that Th1 mediated immunity is important
for the control of Leishmania infection and that oxidants
produced by IFN-γ activated macrophages are the main
final effector molecules killing Leishmania (rev. in [26].
Although, in this report, we observed an increased pro-
duction of TNF-α upon pre-treatment of monocytes with
L. intermedia SGS, this was not associated with decreased
L. braziliensis infection. This effect may be explained by the
parallel up-regulation of both IL-6 and IL-8 production.
IL-6 is produced by cells of both the innate and adaptive
immune responses, and it was recently shown that IL-6 is
able to drive the differentiation of CD4+ Th2 cells by the
early induction of IL-4 in CD4+ T cells [27]. IL-8 guides
polymorphonuclear cell recruitment to the site of infec-
tion, and neutrophils have been shown to act as "Trojan
horses" [28] for Leishmania establishment. Indeed, devel-
opment of clinically evident lesions occurs in parallel with
the influx of inflammatory cells, including neutrophils,
eosinophils and macrophages [29]. Using the air pouch
model of inflammation, we observed a significant
increase in the recruitment of polymorphonuclear cells
upon injection of L. intermedia SGS (de Moura et al., man-
uscript in preparation). In mice exposed to L. intermedia
SGS, a further inoculation of L. intermedia SGS induced an
important inflammatory response comprised of numer-
ous polymorphonuclear and few mononuclear cells [13].
We can thus hypothesize that the increase in IL-8 produc-
tion induced by L. intermedia saliva may lead to neu-
trophil recruitment and, consequently, the successful
establishment of infection. Moreover, it will also be inter-
esting to determine whether L. intermedia saliva also exerts
effects on the effector functions of T-lymphocytes,
employing, for example in vitro priming systems [30,14].
Conclusion
We can conclude that the effects exerted by L. intermedia
saliva on human monocytes are different from those
observed with L. longipalpis saliva [15], Maxadilan alone
[31,25] and P. papatasi saliva [14] and such differences
may play an important role regarding the outcome of
leishmaniasis. Moreover, since it has been proposed that
vaccinating against sand fly salivary components can pro-
tect the host from infection (rev. in [32]), our observa-
tions also suggest a note of caution regarding the
development of vaccines based on sand fly saliva.
Methods
Sand Flies and Preparation of SGS
Lutzomyia intermedia, Corte de Pedra strain, and Lutzomyia
longipalpis, Cavunge strain, were reared at Centro de
Pesquisas Gonçalo Moniz-FIOCRUZ, as described else-
where [33]. Adult sand flies were used for dissection of
Effect of L. intermedia SGS on co-stimulatory molecule  expression on LPS-stimulated human monocytes Figure 2
Effect of L. intermedia SGS on co-stimulatory mole-
cule expression on LPS-stimulated human mono-
cytes. Monocytes were pre-treated with SGS and stimulated 
with LPS for 48 h. Cells were collected and surface molecule 
expression was analyzed by flow cytometry. Mean fluores-
cence intensity of expression is shown for each individual 
tested (*p < 0.05). (n = 8).BMC Immunology 2008, 9:12 http://www.biomedcentral.com/1471-2172/9/12
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salivary glands 3–5 days after emergence. Salivary glands
were stored in groups of 20 pairs in 20 μl NaCl (150 mM)
Hepes buffer (10 mM, pH7.4), at -70°C. Immediately
before use, salivary glands were disrupted by ultrasonica-
tion in 1.5 ml conical tubes. Tubes were centrifuged at
10,000 × g for 2 min and the resultant supernatant (Sali-
vary Gland Sonicate – SGS) was used for the studies. The
level of LPS contamination of SGS preparations was deter-
mined using a commercially available LAL Chromogenic
Kit (QCL-1000, Lonza Bioscience); LPS concentration was
<0.1 ng/ml.
Monocyte Culture
In this work, leukocyte concentrates from healthy adult
blood donors were provided by the Blood Bank
(HEMOBA) from Salvador, Bahia. Informed verbal con-
sent was obtained from blood donors (six male, four
female, age range 30 to 39 years old)
at the time of donation, and all procedures were approved
by the local Ethics Committee (CEP/CPqGM-FIOCRUZ)
and were conducted following recommendations out-
lined in the Helsinki Declaration. PBMC were isolated by
Ficoll-Hypaque (Sigma) density gradient separation. Cells
were then washed, and monocytes were obtained by pos-
itive selection with CD14 magnetic beads (Miltenyi Bio-
tech), following the manufacturer's instructions. Briefly, a
total of 108 cells were resuspended in MACS buffer (PBS/
0.5% BSA/2 mM EDTA) containing CD14 microbeads.
After incubation for 30 min at 4°C, cells were washed and
resuspended in MACS buffer and loaded onto MiniMACS
MS+ Separation Columns (Miltenyi Biotech). Non-adher-
ent cells were recovered and the total number of CD14-
Effect of L. intermedia SGS on cytokine production of LPS-stimulated human monocytes infected with L. braziliensis Figure 3
Effect of L. intermedia SGS on cytokine production of LPS-stimulated human monocytes infected with L. bra-
ziliensis. Monocytes were pre-treated with SGS overnight, stimulated with LPS for 4 h and infected with L. braziliensis for 4 
hours. The presence of IL-10 (A), TNF-α (B), IL-6 (C) and IL-8 (D) was analyzed by ELISA. The data for individual donors are 
presented. (*p < 0.05). (n = 8).BMC Immunology 2008, 9:12 http://www.biomedcentral.com/1471-2172/9/12
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positive monocytes was determined by FACS. The average
yield was usually between 92 and 98%. Purified human
monocytes were resuspended in complete RPMI (RPMI
supplemented with HEPES Buffer 11203, L-glutamine (2
mM), penicillin (100 U/mL), streptomycin (1%) and fetal
calf serum (10%), all from Life Technologies) and were
pre-treated with L. intermedia SGS (equivalent to 2 pairs of
salivary gland/ml or 1 ug/ml of protein) for 12 h, fol-
lowed by stimulation with 20 pg/ml LPS (E. coli
O111:B14 from Sigma). Cultured cells and culture super-
natants were collected 24 h and 48 h later. Co-stimulatory
molecule expression was analyzed by flow cytometry and
cytokine profiles were determined by ELISA.
Flow cytometry
Reagents for staining cell surface markers and intracellular
cytokines were purchased from BD Biosciences, San
Diego, CA. Cells were blocked with anti-Fc receptor anti-
body (2.4G2) and were stained with anti-human CD80
(L307.4), CD86 (2331) and HLA-DR, DP and DQ (G46-
6) conjugated to PE. Isotype controls were used as appro-
priate. For each sample, 20,000 events were analyzed
using CELLQuest™ software and a FACSort® flow cytome-
ter (Becton Dickinson Immunocytometry).
Cytokine assays
Concentrations of TNF-α, IL-6, IL-8, IL-10 and IL-12p40
in culture supernatants were determined by ELISA using
commercial kits (BD Pharmingen), following the manu-
facturer's instructions.
Parasite culture
L. braziliensis strain MHOM/BR/01/BA788 was isolated
from a patient with cutaneous leishmaniasis from the
state of Bahia (northeastern Brazil) after brief (2–4) pas-
sages in culture medium. This isolate was identified as L.
braziliensis by using PCR [34] and monoclonal antibodies
[35]. Promastigotes were grown in Schneider medium
(Sigma) supplemented with 100 U/ml of penicillin, 100
ug/ml of streptomycin and 10% heat-inactivated fetal calf
serum (all from Life Technologies). Monocytes were pre-
treated with SGS as above for twelve hours, stimulated
with LPS for four hours and were infected with L. brazilien-
sis parasites (5 parasites to 1 monocyte) for four hours.
Infected monocytes were washed for removal of parasites
and cultivated for 24 and 48 h. Co-stimulatory molecule
expression was analyzed by flow cytometry and cytokine
profiles were determined by ELISA.
Statistical analysis
Statistical analyses comparing cytokine responses and sur-
face molecule expression were performed using Prism
(GraphPad Software). Data were compared using the Wil-
coxon signed-rank test. In all cases, results were consid-
ered significantly different when the P-value was < 0.05.
Effect of L. intermedia SGS on co-stimulatory molecule  expression of LPS-stimulated human monocytes infected  with L. braziliensis Figure 4
Effect of L. intermedia SGS on co-stimulatory mole-
cule expression of LPS-stimulated human monocytes 
infected with L. braziliensis. Monocytes were pre-treated 
with SGS overnight, stimulated with LPS for 4 h and infected 
with L. braziliensis for 4 hours. Cells were collected 48 h later 
and surface molecule expression was analyzed by flow 
cytometry. Mean fluorescence intensity of expression is 
shown for each individual tested (*p < 0.05). (n = 8).BMC Immunology 2008, 9:12 http://www.biomedcentral.com/1471-2172/9/12
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